Point72 Hong Kong’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,000
Closed -$969K 1037
2022
Q3
$969K Buy
12,000
+6,800
+131% +$611K 0.03% 564
2022
Q2
$467K Sell
5,200
-16,400
-76% -$1.66M 0.02% 736
2022
Q1
$2.4M Buy
21,600
+1,700
+9% +$180K 0.08% 278
2021
Q4
$2.06M Buy
19,900
+2,400
+14% +$278K 0.07% 322
2021
Q3
$2.19M Buy
17,500
+14,700
+525% +$1.9M 0.07% 421
2021
Q2
$348K Buy
2,800
+500
+22% +$62.8K 0.01% 1008
2021
Q1
$272K Sell
2,300
-9,400
-80% -$1.1M 0.01% 983
2020
Q4
$1.37M Buy
+11,700
New +$1.29M 0.06% 377

Other funds holding MDT

Point72 Hong Kong's MDT Position: Q2 2025 in Review

Point72 Hong Kong sold out of Medtronic (MDT) in Q2 2025, closing a stake of 21,680 shares — an estimated $1.95M sold.

Point72 Hong Kong first reported a position in MDT in Q4 2015 and held it in 23 quarters. The position peaked at $10.7M in Q2 2022. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Point72 Hong Kong reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 21,680 Medtronic shares in Q2 2025, an estimated $1.95M.
  • Point72 Hong Kong first reported a position in Medtronic in Q4 2015 and held it in 23 quarters.
  • Point72 Hong Kong's Medtronic position peaked at $10.7M in Q2 2022.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.